Cargando…

Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection

PURPOSE: Platelet-related indices, including mean platelet volume (MPV) and plateletocrit (PCT), have been reported as new prognostic factors of overall survival (OS) in many cancers, but not yet in biliary tract cancer (BTC). We intended to assess these indices in predicting OS in BTC patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Lejia, Wei, Yuxi, Chen, Yang, Hu, Wenmo, Ji, Xin, Xu, Haifeng, Du, Shunda, Zhao, Haitao, Lu, Xin, Sang, Xinting, Zhong, Shouxian, Yang, Huayu, Mao, Yilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053856/ https://www.ncbi.nlm.nih.gov/pubmed/33253516 http://dx.doi.org/10.4143/crt.2020.833

Ejemplares similares

Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers
por: Sun, Lejia, et al.
Publicado: (2021)

High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China
por: Sun, Lejia, et al.
Publicado: (2020)

Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
por: Ke, Xindi, et al.
Publicado: (2021)

Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor
por: Sun, Lejia, et al.
Publicado: (2020)

The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
por: Sun, Lejia, et al.
Publicado: (2020)

Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage
por: Ge, Penglei, et al.
Publicado: (2016)

Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience
por: Sun, Lejia, et al.
Publicado: (2020)

Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival
por: Sun, Lejia, et al.
Publicado: (2021)

The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
por: Jin, Bao, et al.
Publicado: (2021)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy
por: Zheng, Yongchang, et al.
Publicado: (2017)

Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria
por: Xu, Wei, et al.
Publicado: (2017)

Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma: A Meta-Analysis
por: Liao, Wenjun, et al.
Publicado: (2015)

Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases: Large Data From Asia
por: Du, Shunda, et al.
Publicado: (2015)

Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure
por: Yang, Huayu, et al.
Publicado: (2021)

Radiomics based on artificial intelligence in liver diseases: where are we?
por: Hu, Wenmo, et al.
Publicado: (2020)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

Quantitative definitions of prognostic indicators of resectable pancreatic cancer
por: Sun, Hang, et al.
Publicado: (2022)

Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research
por: Jin, Bao, et al.
Publicado: (2022)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric mice
por: Hu, Dandan, et al.
Publicado: (2018)

Public Psychosocial and Behavioral Responses in the First Wave of COVID-19 Pandemic: A Large Survey in China
por: Yang, Huayu, et al.
Publicado: (2021)

Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
por: Liao, Wenjun, et al.
Publicado: (2016)

Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors
por: Du, Shunda, et al.
Publicado: (2015)

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
por: Wang, Yunchao, et al.
Publicado: (2022)

Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
por: Zhang, Junwei, et al.
Publicado: (2020)

Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma
por: Du, Shunda, et al.
Publicado: (2016)

Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis
por: Yang, Huayu, et al.
Publicado: (2019)

Patient-derived organoids: a promising model for personalized cancer treatment
por: Yang, Huayu, et al.
Publicado: (2018)

Laparoscopic hepatectomy for patients who received enterostomy
por: Jin, Bao, et al.
Publicado: (2019)

Application and Progress of Cultured Models of Gallbladder Carcinoma
por: Xing, Jiali, et al.
Publicado: (2023)

Alteration in gut microbiota caused by time‐restricted feeding alleviate hepatic ischaemia reperfusion injury in mice
por: Ren, Jinjun, et al.
Publicado: (2018)

Mutational spectrum and precision oncology for biliary tract carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up
por: Xu, Wei, et al.
Publicado: (2016)

Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research
por: Sun, Lejia, et al.
Publicado: (2020)

Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease
por: Wang, Jiaru, et al.
Publicado: (2021)

Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
por: Li, Changcan, et al.
Publicado: (2022)

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy
por: Wang, Yanan, et al.
Publicado: (2022)

Study on drug screening multicellular model for colorectal cancer constructed by three-dimensional bioprinting technology
por: Wang, Peipei, et al.
Publicado: (2023)

Perioperative management of patients with liver cancer complicated with sarcopenia
por: Xing, Jiali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gshjcf7fegmrfots7qb9kr5439